Back to top

Image: Bigstock

4 of the Best Stocks to Buy on Earnings Acceleration

Read MoreHide Full Article

Since we are in the thick of the earnings season, investors should look for stocks that are ready to make a big move. Upbeat earnings results are more often than not followed by an uptick in the share price. Take a company’s revenues over a given period of time, subtract the cost of production and you will have its earnings!

But earnings acceleration works even better in boosting the stock price. Studies have shown that majority of successful stocks see acceleration in earnings before a positive stock price movement.

Future Outperformers

So, what is earnings acceleration? It is the incremental growth in a company’s earnings per share (EPS). In other words, if the rate of a company’s quarter-over-quarter earnings growth increases within a stipulated frame of time, it can be called earnings acceleration.

In case of earnings growth, you pay for something that is already reflected in the stock price. But, earnings acceleration helps spot stocks that haven’t caught the attention of investors yet, which once secured will invariably lead to a rally in the share price. This is because earnings acceleration considers both direction and magnitude of growth rates.

Increasing percentage of earnings growth means that the company is fundamentally sound and has been on the right track for a considerable period of time. On the other hand, a sideways percentage of earnings growth indicates a period of consolidation or slowdown, while a decelerating percentage of earnings growth may at times drag prices down.

Hence, earnings acceleration should be viewed as a key metric for share price outperformance.

The Winning Strategy

Let’s look at stocks for which the last two quarter-over-quarter percentage EPS growth rates exceed the growth rates of the previous periods. The projected quarter-over-quarter percentage EPS growth rates are also expected to be higher than the previous periods’ growth rates.

EPS % Projected Growth (Q1)/(Q0) greater than EPS % Growth (Q0)/(Q-1): The projected growth rate for the current quarter (Q1) over the completed quarter (Q0) has to be greater than the growth rate from the completed quarter (Q0) over one quarter ago (Q-1).

EPS % Growth (Q0)/(Q-1) greater than EPS % Growth (Q-1)/(Q-2): The growth rate for the completed quarter (Q0) over one quarter ago (Q-1) has to be greater than the growth rate from one quarter ago (Q-1) over two quarters ago (Q-2).

EPS % Growth (Q-1)/(Q-2) greater than EPS % Growth (Q-2)/(Q-3): The growth rate from one quarter ago (Q-1) over two quarters ago (Q-2) has to be greater than the growth rate from two quarters ago (Q-2) over three quarters ago (Q-3).

In addition to this, we have added the following parameters:

Current Price greater than or equal to $5: This screens out the low-priced stocks.

Average 20-day volume greater than or equal to 50,000: High trading volume implies that the stocks have adequate liquidity.

The above criteria narrowed down the universe of around 7,735 stocks to only 27. Here are the top four stocks:

Dollar Tree, Inc. (DLTR - Free Report) operates variety retail stores in the United States and Canada. It operates through two segments, Dollar Tree and Family Dollar. Dollar Tree sports a Zacks Rank #1 (Strong Buy). The company’s estimated earnings growth rate for this year is 29.1%, higher than the industry’s projected addition of 14.2%.

Syndax Pharmaceuticals, Inc. (SNDX - Free Report) a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapies for various cancer indications. Syndax Pharmaceuticals has a Zacks Rank #2 (Buy). The company’s estimated earnings growth rate for this year is 9.3%, ahead of the industry’s estimated gain of 6%. You can see the complete list of today’s Zacks #1 Rank stocks here.

Pinnacle Financial Partners, Inc. (PNFP - Free Report) operates as a bank holding company for Pinnacle Bank that provides various banking products and services in the United States. Pinnacle Financial Partners has a Zacks Rank #2. The company’s estimated earnings growth rate for this year is 15.6%, ahead of the industry’s projected addition of 6.4%.

Union Bankshares Corporation operates as the bank holding company for Union Bank & Trust that provides banking and related financial services to consumers and businesses. Union Bankshares has a Zacks Rank #2. The company, which is part of the Banks - Southeast industry, is expected to yield a solid return of 5.1% this year.

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance

Zacks Restaurant Recommendations: In addition to dining at these special places, you can feast on their stock shares. A Zacks Special Report spotlights 5 recent IPOs to watch plus 2 stocks that offer immediate promise in a booming sector. Download it free »


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Dollar Tree, Inc. (DLTR) - free report >>

Pinnacle Financial Partners, Inc. (PNFP) - free report >>

Syndax Pharmaceuticals, Inc. (SNDX) - free report >>

Published in